版本:
中国

BRIEF-Fibrocell Science Q1 loss per share $0.60

May 10 Fibrocell Science Inc

* Fibrocell reports first quarter 2017 financial results and recent operational highlights

* Q1 loss per share $0.60

* Fibrocell Science Inc - as of march 31, 2017, company had cash and cash equivalents of $20.6 million and working capital of $18.2 million

* Fibrocell Science Inc - company believes that its cash and cash equivalents at march 31, 2017 will be sufficient to fund operations into Q2 of 2018

* Fibrocell Science Inc - expect to submit investigational new drug application to FDA in q4 2017 for fcx-013 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐